Fresenius Medical Care North America (FMCNA) has announced three key clinical leadership appointments to help drive priorities, including improving patient outcomes, adopting connected health technologies to support home dialysis and increasing access to transplantation, according to a company press release.
Kathleen Belmonte has been named chief nursing officer and senior vice president of Clinical Services of Fresenius Kidney Care—the dialysis services division of FMCNA. Benjamin Hippen has been named senior vice president and head of Transplant Medicine as part of the Global Medical Office senior leadership team. Shelly Nash has been appointed senior vice president and chief medical information officer for FMCNA.
“We welcome these exceptional clinical leaders who bring many years of deep experience working both inside and outside our company,” said Bill Valle, CEO of FMCNA. “These individuals will help us continue to be the leader in value-based care and transforming kidney care models that slow disease progression, while improving home dialysis and transplantation rates, clinical quality, and information technology to enhance experiences and affordability for the benefit of employees, physician partners, payors, and most importantly, our patients.”
“This expansion of our executive team underscores our commitment to improving patient outcomes on a global scale by acknowledging new leadership capabilities needed in the company,” said Franklin W Maddux, global chief medical officer for Fresenius Medical Care. “Under their leadership in nursing care, health information technology, and organ transplantation, we will continue to drive innovation, expertise, and credibility that will enhance our ability to provide the highest quality of innovative and holistic care.”
